MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)

HKG:2235 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,537	1,507	1,697	1,886	2,047	2,151
Trading Asset Securities	0.8	39.23	10.22	6.05	-	-
Cash & Short-Term Investments	1,538	1,546	1,707	1,892	2,047	2,151
Cash Growth	-10.77%	-9.46%	-9.75%	-7.56%	-4.85%	228.40%
Accounts Receivable	141.32	144.7	117.82	73.23	49.26	27.77
Other Receivables	2	0.29	0.1	0.09	1.2	4.68
Receivables	143.32	144.99	117.91	73.32	50.46	32.45
Inventory	102.72	79.07	50.81	42.11	67.34	34.17
Other Current Assets	32.4	38.27	28.6	15.8	12.62	15.68
Total Current Assets	1,817	1,808	1,905	2,023	2,177	2,233
Property, Plant & Equipment	237.45	220.87	204.61	101.36	90.62	80.12
Other Intangible Assets	29.79	30.62	31.8	33.74	18.76	13.79
Long-Term Deferred Charges	1.36	0.86	0.11	0.24	0.18	-
Other Long-Term Assets	254.21	249.69	5.02	0.27	7.56	1.96
Total Assets	2,339	2,310	2,146	2,159	2,294	2,329

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	121.95	76.44	33.41	33.1	19.44	14.12
Accrued Expenses	14.71	47.36	43.2	38.46	39.96	21.48
Short-Term Debt	74.19	63.95	-	-	-	-
Current Portion of Leases	0.51	0.49	0.17	0.48	0.45	0.12
Current Income Taxes Payable	1.86	0.22	-	-	-	-
Current Unearned Revenue	45.29	42.54	27.25	7.98	11.86	14.41
Other Current Liabilities	34.89	52.17	62.91	13.36	7.44	32.22
Total Current Liabilities	293.4	283.18	166.93	93.38	79.16	82.34
Long-Term Leases	0.08	0.34	-	0.17	0.26	0.14
Long-Term Unearned Revenue	8.62	9.02	-	-	0.01	-
Long-Term Deferred Tax Liabilities	0.1	0.11	0.14	0.17	0.01	-
Other Long-Term Liabilities	-	3.31	4.66	3.98	2.63	-
Total Liabilities	302.2	295.97	171.72	97.7	82.06	82.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	421.08	421.08	421.14	425.74	425.74	425.74
Additional Paid-In Capital	-	1,867	1,866	1,883	1,883	1,724
Retained Earnings	-204.62	-244.9	-285.05	-221.93	-96.91	20.79
Treasury Stock	-52.96	-35.7	-33.58	-26.25	-	-
Comprehensive Income & Other	1,874	7.13	6.05	0.73	0.42	75.8
Shareholders' Equity	2,037	2,014	1,975	2,061	2,212	2,247
Total Liabilities & Equity	2,339	2,310	2,146	2,159	2,294	2,329

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	74.78	64.79	0.17	0.64	0.72	0.26
Net Cash (Debt)	1,463	1,481	1,707	1,891	2,046	2,151
Net Cash Growth	-13.56%	-13.25%	-9.73%	-7.56%	-4.88%	228.42%
Net Cash Per Share	3.70	3.58	4.06	4.39	4.67	5.76
Filing Date Shares Outstanding	421.08	417.91	419.04	425.74	425.74	425.74
Total Common Shares Outstanding	421.08	417.91	419.04	425.74	425.74	425.74
Working Capital	1,523	1,525	1,738	1,930	2,098	2,151
Book Value Per Share	4.84	4.82	4.71	4.84	5.20	5.28
Tangible Book Value	2,007	1,984	1,943	2,027	2,193	2,233
Tangible Book Value Per Share	4.77	4.75	4.64	4.76	5.15	5.24
Buildings	-	197.04	76.2	74.55	73.26	60.3
Machinery	-	71.09	57.04	47.47	37.41	25.93
Construction In Progress	-	1.18	109.62	7.95	0.38	0.13

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 11, 2026

Data Sources Report a data error